FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/07/2026
Back to search
Official data from USPTO
FIDIA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000079405248Class
1, 3, 5, 10, 41
Filing
79405248
Registration
8200173
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
07/07/2026
Trademark type
Combined
Nice classes
1, 3, 5, 10, 41
Filing date
05/03/2024
Registration date
04/07/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/07/2026
Last transaction
07/07/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
IT
Examiner
STRUCK, ROBERT J
Law office
L90
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized term FIDIA and a design of a Pegasus inside a circle.
Holders and representatives
Holders
Fidia Farmaceutici S.p.A.
Representatives
Andrew N. Fredbeck Fross Zelnick Lehrman & Zissu, P.C.
Technical classification
Nice Classes
Class 1Class 3Class 5Class 10Class 41
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for use in industry; chemicals for use in science; biological preparations for use in industry and science; plant extractsother than essential oilsfor use in the manufacture of pharmaceutical products and cosmetics; preservatives for use in the pharmaceutical industry; emollients for industrial purposes; antioxidants for use in the manufacture of pharmaceutical productscosmetics and nutritional supplements; proteins for use in the manufacture of pharmaceutical productscosmetics and nutritional supplements; vitamins for use in the manufacture of pharmaceutical productscosmetics and nutritional supplements; active chemical ingredients for the production of pharmaceuticals for the treatment of jointsfor the prevention and treatment of traumatic and degenerative joint pathologiesfor the treatment of cancerarthrosisosteoarthritis and diseases of the muscular and skeletal system; active chemical ingredients for the production of pharmaceuticals for use in aesthetic and regenerative care; active chemical ingredients for the production of dermatological preparationsophthalmological preparationsanti-inflammatory preparationsneurological preparationscardiovascular preparations and gynecological preparations; chemical and biological preparations for the manufacture of pharmaceutical productscosmeticsmedicinesdietetic substancesnutritional supplements and health care products
Class 3
Non-medicated cosmetics and toiletry preparations; non-medicated dentifrices; essential oils; non-medicated soaps and bath gelsvaginal washes for personal sanitary or deodorant purposes; non-medicated vaginal douching preparations; shampoos; cosmetic preparations and lotions for hair care and beauty care; topical skin sprays for cosmetic use; dermocosmetic products not for medical usecosmetic preparations for skin care; creamsointmentsbalmslotionsoils and tanning sprayswith sunscreen and after-sun protectionsunscreen preparations and after-sun lotions and creams; mouthwashesnot for medical purposes; oral hygiene preparationsnon-medicated mouth wash and rinse; eye-washesnot for medical purposes; moist wipes for sanitary and cosmetic purposespre-moistened cosmetic wipes; eyeglass wipes impregnated with a detergent; baby wipes impregnated with cleaning preparations
Class 5
Pharmaceutical and medical preparations for the treatment of jointsfor the prevention and treatment of traumatic and degenerative joint pathologies and for use during orthopedic surgery; pharmaceutical and medical preparations for the treatment of arthrosis and osteoarthritis; pharmaceutical and medical preparations for the treatment of rheumatologic diseases; pharmaceutical and medical preparations for the treatment of diseases of the muscular and skeletal system; pharmaceutical and medical preparations for the prevention and treatment of allergic and autoimmune diseasesskin diseasescancer and as an accompanying medication in cancer and pain therapy; dermatological preparations; rheumatological pharmaceutical preparations; ophthalmological preparations; anti-inflammatory preparations; analgesic preparations; gynecological pharmaceutical preparations; analgesic preparations; neurological pharmaceutical preparationscardiovascular pharmaceutical preparations; anticoagulants; pharmaceutical preparations for use in aesthetic and regenerative care; veterinary preparations for equine use to treat conditions of the joints and inflammation; sanitary preparations for medical purposes; dietetic food and beverages adapted for medical and veterinary use; dietary supplements for human beings and animals; medical plasterswadding for dressings; disinfectants; biological preparations for medical purposeshuman allograft tissue matrixes derived from amniotic membraneshuman allograft tissuebiological tissue graftsbiological amniotic membrane tissue intended for injection for subsequent implantation; nutritional supplements with a cosmetic effect; nutritional supplements for human beings; nutritional supplements for animals; adhesive plasters for medical purposes; transdermal patches for the transdermal administration of pharmaceuticals for use in the treatment of dermatological diseases; gauze for dressings; eye drops; medicated eyewash; solutions for contact lenses; solutions for contact lens rinsingsterilizationdisinfectionneutralization; pre-filled syringes for medical purposes sold filled with pharmaceutical preparations for the treatment of jointsfor the prevention and treatment of traumatic and degenerative joint pathologies and for use during orthopedic surgeryfor treatment of arthrosis and osteoarthritisfor the treatment of rheumatologic diseases and for the treatment of diseases of the muscular and skeletal system; surgical implants comprised of living tissues
Class 10
Surgical instruments and apparatus; medical devices for the treatment of woundsburnsulcersdamaged skin and tissuejoint and musculo-skeletal diseases and disorders; Medical apparatus for the preparation and injection of Platelet-Rich Plasma (PRP); Blood processing kits comprised of apparatus for blood collectionseparation of blood componentsprocessing of blood and administration of blood for medical purposes being medical needlesmedical syringessample preparation tubes and vialsholders for sample tubes and vialsblood filters for medical purposes; syringes for medical purposes and cannulae; needles for medical purposes; devices for the injection of pharmaceutical preparations and medicines; medical-surgical devices for the treatment of jointsjoint pathologiestraumatic and degenerative pathologies of the musculo-sketetal system and for use during orthopaedic surgery; surgical implants comprised of artificial materials; implantable subcutaneous drug delivery devicesimplantable drug delivery pumps
Class 41
Educationconducting classesseminars and workshops in the field of healthcareaesthetic carecosmeticsregenerative medicine and pharmaceuticals; arranging and conducting of workshops in the field of healthcareaesthetic care and pharmaceuticals; arranging and conducting of conventionsconferencesseminars in the area of healthcareaesthetic care and pharmaceuticals; organization of exhibitions for cultural or educational purposes; organization of sports competitions; publishing booksmagazines and electronic publications; publication of textsother than publicity texts; publication of the results of clinical trials for pharmaceutical and medical preparations
Publications
History of USPTO decisions and trademark events.
29 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/07/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
04/07/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/12/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/25/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
02/25/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/17/2026
PUBO
PUBLISHED FOR OPPOSITION
02/17/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/11/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/23/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/16/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/16/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/16/2026
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/17/2025
GNRT
NON-FINAL ACTION E-MAILED
07/17/2025
CNRT
NON-FINAL ACTION WRITTEN
07/17/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/10/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/09/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/09/2025
RFNT
REFUSAL PROCESSED BY IB
12/29/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/10/2024
RFRR
REFUSAL PROCESSED BY MPU
12/10/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/26/2024
CNRT
NON-FINAL ACTION WRITTEN
11/25/2024
DOCK
ASSIGNED TO EXAMINER
11/18/2024
MAFR
APPLICATION FILING RECEIPT MAILED
10/03/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/03/2024
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
09/27/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/26/2024
Continuous trademark protection
Get notified about every new filing that threatens FIDIA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.